ColDx

[Anonymous]

Where art thou?

 

[Anonymous]

Thou art at the Cleveland Clinic and being used already. Douche

 

[Anonymous]

Will PTI ever be profitable? LMAO!

 

[Anonymous]

Will PTI ever be profitable? LMAO!

Will you ever get a LIFE?!!!!!!!!!!!!!!!!

 

[Anonymous]

Not that this will stop PTI from selling the product, but I thought this product failed its validation study. Is that not true?

 

[Anonymous]

THis product actually passed its validation study with CALGB.

There was an error by a kit manufacturer and the media that was holding the tumor specimen was faulty for a small subset of patients. These patients were rerun by CALGB, remember this is an independent validation cohort that mirrors genomic health's CALGB study, and they outperformed GH's quite significantly.

So, again, this product has passed validation.

 

[Anonymous]

ultimately grasshoppers, the spots are still on the leopards; leadership comprised of unethical ass clowns who will do or say anything for short term gain.

 

[Anonymous]

The product actually passed validation, performing significantly beter than was expected.

There was a delay because a susbet of patients from the validation were faulty due to a bad media in the specimen kits. These patients were packaged with appropriate kits and had the tests run again by CALGB. Remember, this was an independent validation. Following the re-run coldx outperformed the initial hopes of pti and did better than ocotypedx on the same patient cohort.

So, yes, the test has passed and exceeded all validations.